Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.
1:23-cv-00580
Overview
Parties
Defendant
ModernaTX, Inc. Operating Company
Represented By
11 Attorneys ListedCooley LLP
10265 Science Center Drive, San Diego, CA 92121
Cooley LLP
30 S. 9th Street, 7th Floor
Farnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Moderna, Inc. Operating Company
Represented By
13 Attorneys ListedCooley LLP
10265 Science Center Drive, San Diego, CA 92121
Cooley LLP
30 S. 9th Street, 7th Floor
Farnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Counter Claimant
Moderna US, Inc. Operating Company
Represented By
11 Attorneys ListedCooley LLP
10265 Science Center Drive, San Diego, CA 92121
Cooley LLP
30 S. 9th Street, 7th Floor
Farnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Counter Defendant
Alnylam Pharmaceuticals, Inc. Operating Company
Represented By
10 Attorneys ListedMcDermott Will & Emery LLP
The Brandywine Building, 1000 N. West Street
McDermott Will & Emery LLP
The Brandywine Building, 1000 N. West Street
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc.
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US11590229
Biodegradable lipids for the delivery of active agents
|
Filed: 2022-02-14
Issued: 2023-02-28
|
Active (15.2 yrs remaining)
Expires: 2042-02-14
|
|
|
US11633479
Biodegradable lipids for the delivery of active agents
|
Filed: 2022-02-14
Issued: 2023-04-25
|
Active (15.2 yrs remaining)
Expires: 2042-02-14
|
|
|
US11633480
Biodegradable lipids for the delivery of active agents
|
Filed: 2022-02-14
Issued: 2023-04-25
|
Active (15.2 yrs remaining)
Expires: 2042-02-14
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).
Procedural Motions & Interlocutory Orders
Total Motions
29
Dispositive
0
Granted
2
Denied
0
Pending / Review
21
Motions by Category
Key Dispositive Motions & Rulings